(Q37024404)

17 August 2017

1 reference

title

The metabolic syndrome in East Asians (English)

1 reference

17 August 2017

0 references

1 reference

Khiet C Hoang

1

1 reference

PubMed ID

18059211

17 August 2017

Truc Vy Le

series ordinal

2

1 reference

PubMed ID

18059211

17 August 2017

Nathan D Wong

series ordinal

3

1 reference

17 August 2017

1 January 2007

1 reference

Journal of the cardiometabolic syndrome

17 August 2017

1 reference

17 August 2017

2

1 reference

17 August 2017

4

1 reference

17 August 2017

276-282

1 reference

Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Prevalence of the metabolic syndrome and overweight among adults in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Nutritional aspects in the causation and management of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

The cardiovascular continuum in Asia--a new paradigm for the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

The metabolic syndrome in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Pioglitazone in a subgroup of patients with type 2 diabetes meeting the criteria for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1559-4564.2007.07491.X

10.1111/J.1559-4564.2007.07491.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

18059211